Merastin Reduces Weight, Hip Size in Human Study
News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial.
News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial. The findings were presented at Obesity 2011, the Obesity Society’s annual scientific meeting.
Researchers led by Judith Stern, ScD, professor at the University of California, Davis assigned 100 patients to 800 mg of Merastin or placebo for eight weeks. Subjects were instructed to walk five days a week and follow a standard 2000-calorie diet daily.
Compared to reductions in the placebo group, Merastin supplementation was associated with average reductions of 8.2 lbs in body weight, 2.3 inches in waist size, and 1.3 inches in hip size.
Merastin is a blend of Sphaeranthus indicus flower heads and mangosteen (Garcinia mangostana) fruit rind. Results of the trial were exhibited at last week’s SupplySide West show in Las Vegas.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.
